This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2024. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
| Item | Value |
|---|---|
| Country | United States |
| Wikipedia page | https://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation |
| Best overview URL | https://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation |
| Facebook username | gatesfoundation |
| LinkedIn username | bill-&-melinda-gates-foundation |
| Website | https://www.gatesfoundation.org/ |
| Donations URL | https://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database |
| Twitter username | gatesfoundation |
| Page on philosophy informing donations | https://www.gatesfoundation.org/What-We-Do |
| Grant application process page | https://www.gatesfoundation.org/How-We-Work/General-Information/Grantseeker-FAQ |
| Regularity with which donor updates donations data | continuous updates |
| Regularity with which Donations List Website updates donations data (after donor update) | irregular |
| Lag with which donor updates donations data | months |
| Lag with which Donations List Website updates donations data (after donor update) | years |
| Data entry method on Donations List Website | SQL insertion commands generated by script https://github.com/riceissa/gates-foundation-iati-processing |
Brief history: The Gates Foundation launched in 2000, with precursors starting in the 1990s, financed by the personal wealth of co-founder Bill Gates from Microsoft. Starting 2005, it scaled up its giving significantly after a large funding commitment from Warren Buffett
Brief notes on broad donor philosophy and major focus areas: See https://www.gatesfoundation.org/Who-We-Are/General-Information/Foundation-Factsheet for the grantmaking areas. The four grantmaking areas are the Global Development Program, Global Health Program, Global Policy and Advocacy, and United States Program. Within the United States Program the focus is on K-12 education, the Internet, and emergency relief
Notes on grant publication logistics: Although the Gates Foundation has a grants database on its website, as well as individual grant pages for every grant, we use the IATI data instead, because it can be processed programmatically (the data on the site does not allow for full data download or easy programmatic processing). This leads to a few problems: first, IATI data does not include grants made in the United States, since it focuses on development assistance (DA) spending. Second, IATI data is updated more infrequently. Third, it may sometimes omit some information that is present in the grants database
Full donor page for donor Bill and Melinda gates Foundation
| Item | Value |
|---|---|
| Country | |
| Facebook page | LSTM-90559182297 |
| Website | http://www.lstmed.ac.uk/ |
| Twitter username | @LSTMnews |
| Wikipedia page | https://en.wikipedia.org/wiki/Liverpool_School_of_Tropical_Medicine |
Full donee page for donee Liverpool School of Tropical Medicine
| Item | Value |
|---|
| Cause area | Count | Median | Mean | Minimum | 10th percentile | 20th percentile | 30th percentile | 40th percentile | 50th percentile | 60th percentile | 70th percentile | 80th percentile | 90th percentile | Maximum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | 62 | 434,651 | 1,863,262 | -133,577 | 79,523 | 100,000 | 147,269 | 250,000 | 434,651 | 735,210 | 1,298,932 | 2,074,223 | 4,133,959 | 30,467,755 |
| Global health | 60 | 411,635 | 1,910,882 | -133,577 | 67,673 | 100,000 | 143,388 | 250,000 | 411,635 | 735,210 | 1,298,932 | 2,074,223 | 4,133,959 | 30,467,755 |
| Nutrition | 1 | 434,651 | 434,651 | 434,651 | 434,651 | 434,651 | 434,651 | 434,651 | 434,651 | 434,651 | 434,651 | 434,651 | 434,651 | 434,651 |
| Family planning | 1 | 434,651 | 434,651 | 434,651 | 434,651 | 434,651 | 434,651 | 434,651 | 434,651 | 434,651 | 434,651 | 434,651 | 434,651 | 434,651 |
If you hover over a cell for a given cause area and year, you will get a tooltip with the number of donees and the number of donations.
Note: Cause area classification used here may not match that used by donor for all cases.
| Cause area | Number of donations | Total | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Global health (filter this donor) | 60 | 114,652,927.47 | 796,285.00 | 643,850.00 | 9,705,400.00 | 9,308,023.00 | 12,564,305.04 | 7,128,817.00 | 6,873,207.00 | 5,415,896.00 | 3,649,733.00 | 30,632,201.00 | 27,935,210.43 |
| Nutrition (filter this donor) | 1 | 434,651.00 | 0.00 | 0.00 | 0.00 | 434,651.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Family planning (filter this donor) | 1 | 434,651.00 | 0.00 | 0.00 | 0.00 | 434,651.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total | 62 | 115,522,229.47 | 796,285.00 | 643,850.00 | 9,705,400.00 | 10,177,325.00 | 12,564,305.04 | 7,128,817.00 | 6,873,207.00 | 5,415,896.00 | 3,649,733.00 | 30,632,201.00 | 27,935,210.43 |
Graph of spending by cause area and year (incremental, not cumulative)
Graph of spending by cause area and year (cumulative)
There are no documents associated with this combination of donor and donee.
Graph of all donations (with known year of donation), showing the timeframe of donations
| Amount (current USD) | Amount rank (out of 62) | Donation date | Cause area | URL | Influencer | Notes |
|---|---|---|---|---|---|---|
| 449,990.00 | 28 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support the effective implementation of IRS for VL elimination in India. Entomological monitoring for VL elimination. Investment start date: 6/17/2016 to end date: 5/31/2020. Grantee name: Liverpool School of Tropical Medicine; Aid type: Project-type interventions. Affected countries: India. | |
| 147,269.00 | 44 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to optimize and implement novel pre-clinical research models to robustly test Onchocerca macrofilaricidal drug candidates; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 199,026.00 | 42 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support the effective implementation of IRS for VL elimination in India. Entomological monitoring for VL elimination. Investment start date: 6/17/2016 to end date: 5/31/2020. Grantee name: Liverpool School of Tropical Medicine; Aid type: Project-type interventions. Affected countries: India. | |
| 99,700.00 | 54 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to support the roll out of key population services in Zimbabwe. Kick starting GFATM investments in key pops in Zimbabwe. Investment start date: 12/8/2017 to end date: 7/31/2019. Grantee name: Liverpool School of Tropical Medicine; Aid type: Project-type interventions. Affected countries: Zimbabwe. | |
| 230,000.00 | 40 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support the effective implementation of IRS for VL elimination in India. Entomological monitoring for VL elimination. Investment start date: 6/17/2016 to end date: 5/31/2020. Grantee name: Liverpool School of Tropical Medicine; Aid type: Project-type interventions. Affected countries: India. | |
| 314,150.00 | 36 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to optimize and implement novel pre-clinical research models to robustly test Onchocerca macrofilaricidal drug candidates; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 793,415.00 | 23 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to develop and test a manualized, participatory self-help-group program for female sex workers in Harare which can be then be scaled up to other areas of Zimbabwe and the region; Aid type: Project-type interventions. Affected countries: Zimbabwe. | |
| 2,000,043.00 | 14 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to create new specifications that will improve the availability of novel vector control tools to prevent transmission of malaria; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 394,941.00 | 34 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to understand host factors associated with infection of tuberculosis in order to develop new diagnostic tools, host-directed therapeutics or vaccines; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 100,000.00 | 48 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support efforts to eliminate malaria by building an open source software platform implementing features from two existing disease data management platforms including insect monitoring, outbreak alerts, and intervention planning; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 79,523.00 | 56 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to determine if live attenuated influenza vaccine (LAIV) or trivalent influenza vaccine (TIV) affects the density and / or duration of pneumococcal colonization in healthy adults using the EHPC (Experimental Human Pneumococcal Carriage) model; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 1,800,000.00 | 15 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to optimize the phased transition of the Indian Visceral Leishmaniasis indoor residual spraying program; Aid type: Project-type interventions. Affected countries: India. | |
| 1,499,890.00 | 18 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop methods to identify environmental reservoirs of S. Typhi, and use these findings to inform targeted intervention strategies for typhoid fever through spatial modeling; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 43,326.00 | 59 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to make a detailed clinical and epidemiological description of the Typhoid fever epidemic in Blantyre, Malawi, including the association between Typhoid and HIV, morbidity including “surgical” disease (perforation and hemorrhage), mortality and risk facto; Aid type: Project-type interventions. Affected countries: Malawi. | |
| 305,555.00 | 37 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to generate evidence and a prediction model to inform vaccine scheduling and the design of alternative Pneumococcal conjugate vaccine regimens focused on reducing carriage, person-to-person transmission and optimizing herd protection from disease; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| 2,621,034.00 | 10 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support the effective implementation of IRS for VL elimination in India. Entomological monitoring for VL elimination. Investment start date: 6/17/2016 to end date: 5/31/2020. Grantee name: Liverpool School of Tropical Medicine; Aid type: Project-type interventions. Affected countries: India. | |
| 86,704.00 | 55 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to eliminate African sleeping sickness by preventing parasite transmission through vector control using insecticide-treated ‘tiny targets’; Aid type: Project-type interventions. Affected regions: Africa. | |
| -86,704.00 | 61 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support the design of tsetse fly traps for palpalis-group (West African) vectors of sleeping sickness, which will evaluate the deployment parameters and phase 3 impact on sleeping sickness in field evaluations; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| 67,673.00 | 57 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to gain evidence on impact of insecticide resistance on the efficacy of malaria vector control and on the feasibility of managing resistance; Aid type: Project-type interventions. Affected countries: India. | |
| 434,651.00 | 29 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to promote use of data for decision-making, summative assessments on key interventions’ effectiveness, and process tracking and assessments of responsiveness and sustainability; Aid type: Project-type interventions. Affected countries: India. | |
| 434,651.00 | 29 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to promote use of data for decision-making, summative assessments on key interventions’ effectiveness, and process tracking and assessments of responsiveness and sustainability; Aid type: Project-type interventions. Affected countries: India. | |
| 434,651.00 | 29 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | to promote use of data for decision-making, summative assessments on key interventions’ effectiveness, and process tracking and assessments of responsiveness and sustainability; Aid type: Project-type interventions. Affected countries: India. | |
| 434,651.00 | 29 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to promote use of data for decision-making, summative assessments on key interventions’ effectiveness, and process tracking and assessments of responsiveness and sustainability; Aid type: Project-type interventions. Affected countries: India. | |
| 3,491,050.00 | 9 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop a novel anti-Wolbachia (A-WOL) based macrofilaricidal drug for the treatment of onchocerciasis and lymphatic filariasis that is capable of achieving clinical cure within a specified dosage regimen; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 250,000.00 | 38 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support the development of the strategy for the overall coordination of the control and elimination of Onchocerciasis and other Neglected Tropical Diseases in endemic countries with a more collaborative approach from partners; Aid type: Project-type interventions. Affected regions: Africa. | |
| 2,238,286.00 | 12 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to optimize the phased transition of the Indian Visceral Leishmaniasis indoor residual spraying program; Aid type: Project-type interventions. Affected countries: India. | |
| 479,743.00 | 27 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to make a detailed clinical and epidemiological description of the Typhoid fever epidemic in Blantyre, Malawi, including the association between Typhoid and HIV, morbidity including “surgical” disease (perforation and hemorrhage), mortality and risk facto; Aid type: Project-type interventions. Affected countries: Malawi. | |
| 1,233,105.00 | 20 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to optimize the phased transition of the Indian Visceral Leishmaniasis indoor residual spraying program; Aid type: Project-type interventions. Affected countries: India. | |
| 603,149.00 | 26 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to understand host factors associated with infection of tuberculosis in order to develop new diagnostic tools, host-directed therapeutics or vaccines; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 143,388.00 | 45 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to assess the effect of malaria on childhood growth. Does childhood growth depend on malaria? A spatio-temporal analysis. Investment start date: 1/20/2015 to end date: 4/1/2016. Grantee name: Liverpool School of Tropical Medicine; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 2,518,294.00 | 11 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to determine if live attenuated influenza vaccine (LAIV) or trivalent influenza vaccine (TIV) affects the density and / or duration of pneumococcal colonization in healthy adults using the EHPC (Experimental Human Pneumococcal Carriage) model; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 250,000.00 | 38 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support the overall coordination of the control and elimination of Lymphatic Filariasis, onchocerciasis, Soil Transmitted Helminths, and schistosomiasis in endemic countries with a more collaborative approach from partners; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 1,005,644.00 | 21 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to optimize and implement novel pre-clinical research models to robustly test Onchocerca macrofilaricidal drug candidates; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 1,298,932.00 | 19 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop a novel anti-Wolbachia (A-WOL) based macrofilaricidal drug for the treatment of onchocerciasis and lymphatic filariasis that is capable of achieving clinical cure within a specified dosage regimen; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 1,741,843.00 | 16 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to generate evidence and a prediction model to inform vaccine scheduling and the design of alternative Pneumococcal conjugate vaccine regimens focused on reducing carriage, person-to-person transmission and optimizing herd protection from disease; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| 750,040.04 | 24 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to demonstrate the utility and impact of a novel vector control strategy based on the targeted dissemination of insecticides to larval habitats by adult mosquitoes while targeting malaria and dengue; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| 4,999,552.00 | 3 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to eliminate African sleeping sickness by preventing parasite transmission through vector control using insecticide-treated ‘tiny targets’; Aid type: Project-type interventions. Affected regions: Africa. | |
| -48,773.00 | 60 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to fund the establishment of anti-symbiotic chemotherapy directed against Wolbachia bacterial endosymbionts for the control and treatment of human filariasis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 48,773.00 | 58 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop a safe macrofilaricide treatment regime for onchocerciasis and lymphatic filariasis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 2,074,223.00 | 13 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to improve the impact of Indoor Residual Spraying (IRS) of insecticides in Bihar State, India by developing and validating a Visceral Leishmaniasis Decision Support System, which would then be made available free of charge to control programme operators i; Aid type: Project-type interventions. Affected countries: India. | |
| 100,000.00 | 48 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to enable high-throughput screening of candidate drugs for treating infections caused by parasitic filarial worms by developing a cell line derived from the worms that can proliferate continuously in vitro.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 100,000.00 | 48 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to promote safer and more effective treatment strategies for parasite infections by generating models based on satellite imaging and geographical data to predict the locations of the insect vectors that transmit these diseases.; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| 411,635.00 | 33 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to evaluate new and existing drug-based interventions and vector control measures to improve the control of MiP across the range of malaria transmission settings in order to save the lives of mothers and their infants; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: North & Central America|Developing countries, unspecified|South of Sahara|South & Central Asia. | |
| 4,133,959.00 | 7 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop a safe macrofilaricide treatment regime for onchocerciasis and lymphatic filariasis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 100,000.00 | 48 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | To identify new drugs for treating common human parasitic diseases caused by nematode worms that target their essential bacterial symbiont, Wolbachia, by developing a screening strategy based on the model nematode Caenorhabditis elegans.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 100,000.00 | 48 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | To improve treatments for common and debilitating filarial infections by developing the first small animal model of the parasitic disease onchocerciasis for in vitro drug screening and preclinical testing of candidate drugs.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 109,000.00 | 47 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support the design of tsetse fly traps for palpalis-group (West African) vectors of sleeping sickness, which will evaluate the deployment parameters and phase 3 impact on sleeping sickness in field evaluations; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| 1,537,867.00 | 17 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | for general operating support. General Operating Support. Investment start date: 12/20/2012 to end date: 3/31/2013. Grantee name: Liverpool School of Tropical Medicine; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| 4,999,277.00 | 4 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop a novel anti-Wolbachia (A-WOL) based macrofilaricidal drug for the treatment of onchocerciasis and lymphatic filariasis that is capable of achieving clinical cure within a specified dosage regimen; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 336,063.00 | 35 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to evaluate new and existing drug-based interventions and vector control measures to improve the control of MiP across the range of malaria transmission settings in order to save the lives of mothers and their infants; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: North & Central America|Developing countries, unspecified|South of Sahara|South & Central Asia. | |
| -133,577.00 | 62 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to prevent disease (Human African Trypanosomiasis) through research to develop an effective vector control strategy; Aid type: Project-type interventions. Affected regions: Africa. | |
| 133,577.00 | 46 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support the design of tsetse fly traps for palpalis-group (West African) vectors of sleeping sickness, which will evaluate the deployment parameters and phase 3 impact on sleeping sickness in field evaluations; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| 200,000.00 | 41 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to evaluate new and existing drug-based interventions and vector control measures to improve the control of MiP across the range of malaria transmission settings in order to save the lives of mothers and their infants; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: North & Central America|Developing countries, unspecified|South of Sahara|South & Central Asia. | |
| 998,437.00 | 22 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to further refine and evaluate the reproducibility of the Experimental Human Pneumococcal Carriage; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 4,217,459.00 | 5 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support the design of tsetse fly traps for palpalis-group (West African) vectors of sleeping sickness, which will evaluate the deployment parameters and phase 3 impact on sleeping sickness in field evaluations; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| 3,549,733.00 | 8 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to demonstrate the utility and impact of a novel vector control strategy based on the targeted dissemination of insecticides to larval habitats by adult mosquitoes while targeting malaria and dengue; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| 100,000.00 | 48 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to utilize an intranasal inoculation with a safe strain of the bacteria to study the mechanisms of mucosal immunity in the lungs and to explore the potential for a vaccine based on his findings.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 30,467,755.00 | 1 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to evaluate new and existing drug-based interventions and vector control measures to improve the control of MiP across the range of malaria transmission settings in order to save the lives of mothers and their infants; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: North & Central America|Developing countries, unspecified|South of Sahara|South & Central Asia. | |
| 164,446.00 | 43 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to reduce the adverse effects of malaria in pregnancy. Start-up activities of Malaria in Pregnancy Working Group. Investment start date: 9/27/2005 to end date: 1/31/2008. Grantee name: Liverpool School of Tropical Medicine; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 735,210.43 | 25 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to fund the establishment of anti-symbiotic chemotherapy directed against Wolbachia bacterial endosymbionts for the control and treatment of human filariasis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 4,200,000.00 | 6 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to prevent disease (Human African Trypanosomiasis) through research to develop an effective vector control strategy; Aid type: Project-type interventions. Affected regions: Africa. | |
| 23,000,000.00 | 2 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to fund the establishment of anti-symbiotic chemotherapy directed against Wolbachia bacterial endosymbionts for the control and treatment of human filariasis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. |